Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 13772 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
  Instructions 
  Search 
  IPS 
  My preferences 

 


This article has been cited by
1The Effect of Cyp2d6 Gene Polymorphism on the Efficacy and Safety of Mirtazapine in Patients with Depressive Disorders Comorbid with Alcohol
Mikhail S. Zastrozhin,Valery V. Smirnov,Alexander S. Sorokin,Elena A. Grishina,Kristina A. Ryzhikova,Valery V. Shipitsyn,Ludmila M. Savchenko,Oleg Z. Buzik,Sergey S. Koporov,Evgeny A. Bryun,Dmitry A. Sychev
Annals of the Russian academy of medical sciences.2019;74(3)185
[DOI]
2Influence of CYP3A Activity on the Efficacy and Safety of Fluvoxamine in Patients Depressive Disorders and Comorbid Alcohol Use Disorder
Mikhail S. Zastrozhin,Valery V. Smirnov,Alexander S. Sorokin,Elena A. Grishina,Kristina A. Ryzhikova,Inessa A. Bedina,Valery V. Shipitsyn,Ludmila M. Savchenko,Oleg Zh. Buzik,Sergey S. Koporov,Evgeny ?. Bryun,Dmitry A. Sychev
Annals of the Russian academy of medical sciences.2018;73(6)411
[DOI]
3Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross–sectional analysis of baseline data from PERFORM-J
Tomiki Sumiyoshi,Koichiro Watanabe,Shinichi Noto,Shigeru Sakamoto,Yoshiya Moriguchi,Kristin Hui Xian Tan,Lene Hammer-Helmich,Jovelle Fernandez
Journal of Affective Disorders.2019;258(6)172
[DOI]
4Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder
M.S. Zastrozhin,V.Y. Skryabin,V.V. Smirnov,E.A. Grishina,K.A. Ryzhikova,E.M. Chumakov,E.A. Bryun,D.A. Sychev
Canadian Journal of Physiology and Pharmacology.2019;97(8)781
[DOI]
5Depression treatment use among stroke individuals with depression: A cross-sectional analysis of the Medical Expenditure Panel Survey
Raj Desai,Kalyani Sonawane
Research in Social and Administrative Pharmacy.2018;97(8)781
[DOI]
6Perceptions of waived juvenile defendants across mental health diagnoses and demographic characteristics
Melanie Taylor,Tatyana Kaplan,Philip Mulvey,Monica K. Miller
International Journal of Law and Psychiatry.2019;66(8)101474
[DOI]
7The Outcome of Two Occupational Therapy Group Programs on the Social Functioning of Individuals with Major Depressive Disorder
Enos M. Ramano,Marianne de Beer
Occupational Therapy in Mental Health.2019;66(8)1
[DOI]
8Abnormal Hippocampal Subfields May Be Potential Predictors of Worse Early Response to Antidepressant Treatment in Drug-Naïve Patients With Major Depressive Disorder
Xiaoxiao Hu,Lianqing Zhang,Xinyu Hu,Lu Lu,Shi Tang,Hailong Li,Xuan Bu,Qiyong Gong,Xiaoqi Huang
Journal of Magnetic Resonance Imaging.2019;49(6)1760
[DOI]
9IGF-1 defends against chronic-stress induced depression in rat models of chronic unpredictable mild stress through the PI3K/Akt/FoxO3a pathway
Wei-Hong Kuang,Zai-Quan Dong,Lian-Tian Tian,Jin Li
The Kaohsiung Journal of Medical Sciences.2018;34(7)370
[DOI]
10Treatment of military-related post-traumatic stress disorder: challenges, innovations, and the way forward
David Forbes,David Pedlar,Amy B. Adler,Clare Bennett,Richard Bryant,Walter Busuttil,John Cooper,Mark C. Creamer,Nicola T. Fear,Neil Greenberg,Alexandra Heber,Mark Hinton,Mal Hopwood,Rakesh Jetly,Ellie Lawrence-Wood,Alexander McFarlane,Olivia Metcalf,Meaghan O’Donnell,Andrea Phelps,J. Don Richardson,Nicole Sadler,Paula P. Schnurr,Marie-Louise Sharp,James M. Thompson,Robert J. Ursano,Miranda Van Hooff,Darryl Wade,Simon Wessely
International Review of Psychiatry.2019;31(1)95
[DOI]